SPG
55
-3
TEL
72
-2
PEP
48
-2
GE
70
-2
HUM
34
-8
EMC
54
-2
NAVI
40
5
SNA
50
-3
BRK.B
43
-6
NWL
58
-2
SIG
52
5
EW
57
7
ADM
44
-7
TMO
50
-4
PSX
29
-10
TRV
48
-10
JNJ
57
-3
MCO
64
2
HPE
66
3
NOV
47
-6
SPG
55
-3
TEL
72
-2
PEP
48
-2
GE
70
-2
HUM
34
-8
EMC
54
-2
NAVI
40
5
SNA
50
-3
BRK.B
43
-6
NWL
58
-2
SIG
52
5
EW
57
7
ADM
44
-7
TMO
50
-4
PSX
29
-10
TRV
48
-10
JNJ
57
-3
MCO
64
2
HPE
66
3
NOV
47
-6
Financhill
Back

VictoryShares US Value Momentum ETF Vs. Nektar Therapeutics Industry Stock Comparison

Sell
47

ULVM
VictoryShares US Value Momentum ETF

Last Price:
$93.00
Seasonality Move:
0.71%
Sell
42

NKTR
Nektar Therapeutics

Last Price:
$45.42
Seasonality Move:
11.58%
Sell
47
VictoryShares US Value Momentum ETF (ULVM) is a Sell

Is VictoryShares US Value Momentum ETF a Buy, Sell or Hold?

  • The current VictoryShares US Value Momentum ETF [ULVM] share price is $91.44. The Score for ULVM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • ULVM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $49.16. The Score for NKTR is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ULVM Stock Price Chart

What is VictoryShares US Value Momentum ETF's stock price today?

  • The VictoryShares US Value Momentum ETF share price today is $91.44
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ULVM is experiencing selling pressure, which indicates risk of future bearish movement.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $49.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing slight buying pressure.

ULVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.59 Buy
Relative Strength Index (14 RSI): 53.47 Buy
Chaikin Money Flow: -1374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.43 Sell
Relative Strength Index (14 RSI): 38.92 Sell
Chaikin Money Flow: 341847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

ULVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.76 Sell
20-day SMA: 91.03 Buy
50-day SMA: 90.24 Buy
200-day SMA: 85.06 Buy
8-day EMA: 91.74 Sell
20-day EMA: 91.24 Buy
50-day EMA: 88.67 Buy
200-day EMA: 55.92 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.87 Sell
20-day SMA: 57.43 Sell
50-day SMA: 58.05 Sell
200-day SMA: 31.04 Buy
8-day EMA: 54.11 Sell
20-day EMA: 56.28 Sell
50-day EMA: 55.42 Sell
200-day EMA: 38.13 Buy

VictoryShares US Value Momentum ETF Earnings Growth & ULVM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and a decrease next year of $0.27 per share.

VictoryShares US Value Momentum ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):